Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.27B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.23B |
| 3 |
SPDR Gold Trust
GLD
|
+$710M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$662M |
| 5 |
Abbott
ABT
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$932M |
| 3 |
TransDigm Group
TDG
|
+$833M |
| 4 |
MPLX
MPLX
|
+$616M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.4% |
| 2 | Financials | 10.07% |
| 3 | Consumer Discretionary | 8.39% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
HealthStream
HSTM
$871M
| $1.47M | ﹤0.01% |
59,219
+2,670
| +5% | +$64.2K |
|
|
GBL
4177
DELISTED
GAMCO Investors, Inc.
GBL
| $1.47M | ﹤0.01% |
59,193
+7,544
| +15% | +$209K |
|
|
HUD
4178
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $1.47M | ﹤0.01% |
+92,271
| New | +$1.48M |
|
4179
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$191M
| $1.47M | ﹤0.01% |
69,085
-40,330
| -37% | -$904K |
|
|
SPPP
4180
Sprott Physical Platinum and Palladium Trust
SPPP
$610M
| $1.47M | ﹤0.01% |
172,009
-238
| -0.1% | -$2.19K |
|
4181
Scully Royalty
SRL
$87.6M
| $1.47M | ﹤0.01% |
235,937
+20,424
| +9% | +$136K |
|
|
ATRS
4182
DELISTED
Antares Pharma, Inc.
ATRS
| $1.46M | ﹤0.01% |
664,736
-128,862
| -16% | -$290K |
|
4183
Central Garden & Pet Co
CENT
$2.76B
| $1.46M | ﹤0.01% |
42,529
+12,628
| +42% | +$399K |
|
4184
Barings BDC
BBDC
$897M
| $1.46M | ﹤0.01% |
131,331
+2,788
| +2% | +$30.3K |
|
4185
Seres Therapeutics
MCRB
$50.8M
| $1.46M | ﹤0.01% |
9,953
+4,522
| +83% | +$867K |
|
|
LJPC
4186
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.46M | ﹤0.01% |
48,917
-4,321
| -8% | -$139K |
|
4187
Bruker
BRKR
$7.66B
| $1.46M | ﹤0.01% |
48,682
-108,188
| -69% | -$3.51M |
|
|
EGIO
4188
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.46M | ﹤0.01% |
8,857
+4,830
| +120% | +$824K |
|
|
ALTA
4189
DELISTED
Altabancorp
ALTA
| $1.46M | ﹤0.01% |
45,082
-212
| -0.5% | -$6.67K |
|
4190
Direxion Daily Energy Bull 2X ETF
ERX
$225M
| $1.46M | ﹤0.01% |
5,289
+3,397
| +180% | +$1.11M |
|
|
CNBKA
4191
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $1.45M | ﹤0.01% |
18,285
-151
| -0.8% | -$11.8K |
|
|
TBNK
4192
DELISTED
Territorial Bancorp Inc.
TBNK
| $1.45M | ﹤0.01% |
48,728
+4,725
| +11% | +$145K |
|
4193
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$23.1M
| $1.44M | ﹤0.01% |
29,347
-627
| -2% | -$32K |
|
4194
StoneX
SNEX
$9.1B
| $1.44M | ﹤0.01% |
170,819
-136,465
| -44% | -$1.15M |
|
4195
Evogene
EVGN
$7.87M
| $1.44M | ﹤0.01% |
45,703
+863
| +2% | +$32.1K |
|
4196
PhenixFIN
PFX
$83.1M
| $1.44M | ﹤0.01% |
18,044
+1,906
| +12% | +$175K |
|
|
SREV
4197
DELISTED
ServiceSource International, Inc.
SREV
| $1.44M | ﹤0.01% |
377,157
+174,441
| +86% | +$625K |
|
4198
Madrigal Pharmaceuticals
MDGL
$11.7B
| $1.44M | ﹤0.01% |
12,300
+2,183
| +22% | +$269K |
|
|
MQT
4199
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $1.44M | ﹤0.01% |
118,410
+13,664
| +13% | +$169K |
|
4200
UroGen Pharma
URGN
$1.94B
| $1.43M | ﹤0.01% |
28,857
-4,555
| -14% | -$228K |
|
Similar funds
Morgan Stanley's Q1 2018 Portfolio in Review
As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
- Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
- Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
- Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
- Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
- Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
- Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.
Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.